CrushSCI.com
101.5平均天数
115.5中位天数
34最短天数
173最长天数
2042025发文量

Paper Review Records

全部论文审稿周期

6 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

34 天

Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study

作者
Ibuki Tsuru; Satoru Taguchi; Ryo Tanaka; Taketo Kawai; Tomoyuki Kaneko; Yu Nakamura; Yoshifumi Miyauchi; Hayato Hoshina; Daisuke Obinata; Masashi Koshiba; Masashi Shiozaki; Jun Takahashi; Masato Kano; Akihiro Naito; Shohei Suda; Michio Noda; Nozomi Sugiyama; Takehiro Tanaka; Yukari Uemura; Jimpei Miyakawa; Jun Kamei; Shigenori Kakutani; Aya Niimi; Yuta Yamada; Yusuke Sato; Yukio Yamada; Hiroaki Nishimatsu; Takashi Murata; Sayuri Takahashi; Tappei Takada; Yoshiyuki Akiyama; Satoru Takahashi; Tetsuya Fujimura; Hiroshi Fukuhara; Tohru Nakagawa; Haruki Kume展开收起
作者单位
1. Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 2. Department of Urology, International University of Health and Welfare Ichikawa Hospital, Chiba, Japan; 3. Department of Urology, Teikyo University School of Medicine, Tokyo, Japan; 4. Department of Urology, Kyorin University School of Medicine, Tokyo, Japan; 5. Department of Urology, Jichi Medical University, Tochigi, Japan; 6. Department of Urology, Nihon University School of Medicine, Tokyo, Japan; 7. Department of Urology, Shinshu University School of Medicine, Nagano, Japan; 8. Department of Urology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 9. Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan; 10. Department of Urology, The Fraternity Memorial Hospital, Tokyo, Japan; 11. Department of Urology, Musashino Red Cross Hospital, Tokyo, Japan; 12. Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan; 13. Biostatistics Section, Department of Data Science, Center of Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; 14. Department of Urology, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan展开收起
PDF源文件 DOI 网页
124 天

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery

作者
Go Makimoto; Toshio Kubo; Isao Oze; Kadoaki Ohashi; Katsuyuki Hotta; Masahiro Tabata; Junichi Soh; Shinichi Toyooka; Kuniaki Katsui; Nagio Takigawa; Mitsune Tanimoto; Katsuyuki Kiura展开收起
作者单位
1. Department of Allergy and Respiratory Medicine, Okayama University Hospital; 2. Center for Clinical Oncology, Okayama University Hospital, Okayama; 3. Division of Molecular & Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya; 4. Center of Innovative Clinical Medicine, Okayama University Hospital, Okayama; 5. Department of Thoracic Surgery, Okayama University Hospital; 6. Department of Proton Beam Therapy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; 7. Department of General Internal Medicine 4, Kawasaki Hospital, Kawasaki Medical School, Okayama; 8. Department of Hematology, National Hospital Organization Iwakuni Clinical Center, Yamaguchi, Japan展开收起
PDF源文件 DOI 网页
132 天

The effect of escalating the boost dose for patients with involved resection margin after breast-conserving surgery

作者
Sunmin Park; Seung Do Ahn; Eun Kyung Choi; Su Ssan Kim展开收起
作者单位
1. Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea展开收起
PDF源文件 DOI 网页
173 天

Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors

作者
Yoko Yamada; Hirofumi Mukai; Yuta Tokudome; Motoko Kaneko; Kosuke Kashiwabara; Noriaki Wada展开收起
作者单位
1. Department of Breast Oncology, Saitama Cancer Center, Saitama; 2. Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba; 3. Department of Pharmacy, Kyoundo Hospital, Tokyo; 4. Department of Pharmacy, Yamagata University Hospital, Yamagata; 5. Department of Biostatistics, School of Public Health, Graduate School of Medicine, the University of Tokyo, Tokyo; 6. Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan展开收起
PDF源文件 DOI 网页
39 天

Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia

作者
Ryoko Inaba Higashiyama; Shinichi Makita; Akiko Miyagi Maeshima; Dai Maruyama展开收起
作者单位
1. Department of Hematology, National Cancer Center Hospital; 2. Department of Pathology, National Cancer Center Hospital, Tokyo, Japan展开收起
PDF源文件 DOI 网页
107 天

Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma

作者
Hidetaka Nomura; Yuko Sugiyama; Terumi Tanigawa; Maki Matoda; Sanshiro Okamoto; Kohei Omatsu; Hiroyuki Kanao; Kazuyoshi Kato; Kuniko Utsugi; Nobuhiro Takeshima展开收起
作者单位
1. Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan展开收起
PDF源文件 DOI 网页

FAQ

JAPANESE JOURNAL OF CLINICAL ONCOLOGY审稿要多久?

截至2026-11-19,CrushSCI 收录了 JAPANESE JOURNAL OF CLINICAL ONCOLOGY 的 6 篇完整审稿记录。最快一篇从收稿到录用用了 34 天(Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study,2026-05-22 收稿,2026-06-25 录用),最慢一篇用了 173 天;平均 101.5 天,中位数 115.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。